Advancing Hemodynamic Monitoring Edwards pioneered the practice of hemodynamic monitoring with the launch of the Swan-Ganz catheter in the  1970 s, and our products continue to be considered the gold standard in critical care medicine today. Millions of patients have benefited from Edwards’ world-leading hemodynamic monitoring technologies, which enable clinicians to assess a patient’s heart function, balance their oxygenation and make treatment decisions if a patient’s hemodynamic balance is compromised. The latest addition to Edwards’ leading Swan-Ganz product line is our CCOmbo V catheter technology, which, when used in tandem with our advanced Vigilance monitor, is the first to provide clinicians a complete picture of a patient’s hemodynamic state using a single system. The automatic, continuous end-diastolic volume measurement and other hemodynamic data made possible by these products enable clinicians to perform optimal patient monitoring, while also allowing them to devote more time to the delivery of patient care. This best- in-class solution is another example of how Edwards is continuing to advance the treatment of critically ill patients.